Terms: = Breast cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL
2030 results:
1. Photocell-Based Optofluidic Device for Clogging-Free Cell Transit Time Measurements.
Storti F; Bonfadini S; Bondelli G; Vurro V; Lanzani G; Criante L
Biosensors (Basel); 2024 Mar; 14(4):. PubMed ID: 38667147
[TBL] [Abstract] [Full Text] [Related]
2. Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma.
Cipolla C; Lupo S; Grassi N; Tutino G; Greco M; Eleonora D; Gebbia V; Valerio MR
World J Surg Oncol; 2024 Apr; 22(1):100. PubMed ID: 38627759
[TBL] [Abstract] [Full Text] [Related]
3. Differentiation of invasive ductal and lobular carcinoma of the breast using MRI radiomic features: a pilot study.
Maiti S; Nayak S; Hebbar KD; Pendem S
F1000Res; 2024; 13():91. PubMed ID: 38571894
[TBL] [Abstract] [Full Text] [Related]
4. Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance.
Wang J; Li B; Luo M; Huang J; Zhang K; Zheng S; Zhang S; Zhou J
Signal Transduct Target Ther; 2024 Apr; 9(1):83. PubMed ID: 38570490
[TBL] [Abstract] [Full Text] [Related]
5. Intraoperative Evaluation of breast Tissues During breast cancer Operations Using the MasSpec Pen.
Garza KY; King ME; Nagi C; DeHoog RJ; Zhang J; Sans M; Krieger A; Feider CL; Bensussan AV; Keating MF; Lin JQ; Sun MW; Tibshirani R; Pirko C; Brahmbhatt KA; Al-Fartosi AR; Thompson AM; Bonefas E; Suliburk J; Carter SA; Eberlin LS
JAMA Netw Open; 2024 Mar; 7(3):e242684. PubMed ID: 38517441
[TBL] [Abstract] [Full Text] [Related]
6. A prospective study evaluating patient reported outcome measures in patients who have undergone chest wall perforator flaps.
Laroiya I; Tan M; Kaehne A; Shetty G
J Plast Reconstr Aesthet Surg; 2024 Apr; 91():79-82. PubMed ID: 38402816
[TBL] [Abstract] [Full Text] [Related]
7. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
8. Leucine-rich repeats and immunoglobulin-like domains protein 1 (LRIG1) is downregulated in Invasive ductal carcinoma and potential prognostic marker of breast cancer.
Piracha ZZ; Saeed U
J Cancer Res Ther; 2023 Oct; 19(7):1870-1879. PubMed ID: 38376291
[TBL] [Abstract] [Full Text] [Related]
9. Metastatic profiles and survival differences between infiltrating ductal carcinoma and infiltrating lobular carcinoma in invasive breast cancer.
Cavaller L; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
J Gynecol Obstet Hum Reprod; 2024 Apr; 53(4):102740. PubMed ID: 38311000
[TBL] [Abstract] [Full Text] [Related]
10. Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patients.
Agaoglu NB; Unal B; Hayes CP; Walker M; Ng OH; Doganay L; Can ND; Rana HQ; Ghazani AA
Cancer Med; 2024 Feb; 13(3):e6852. PubMed ID: 38308423
[TBL] [Abstract] [Full Text] [Related]
11. [A Case of Triple Negative breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
[TBL] [Abstract] [Full Text] [Related]
12. Immunohistochemical Expression of Autophagy-Related Marker (LC3B) and Stem Cell Marker (CD44) in Molecular Subtypes of breast cancer.
El-Deek HEM; El-Naggar MS; Sayed SG
Asian Pac J Cancer Prev; 2024 Jan; 25(1):145-152. PubMed ID: 38285778
[TBL] [Abstract] [Full Text] [Related]
13. Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway.
Mahlow J; Barry M; Albertson DJ; Jo YJ; Balatico M; Seasor T; Gebrael G; Kumar SA; Sayegh N; Tripathi N; Agarwal N; Swami U; Sirohi D
Hum Pathol; 2024 Feb; 144():28-33. PubMed ID: 38278448
[TBL] [Abstract] [Full Text] [Related]
14. Tumor microenvironment and immune system preservation in early-stage breast cancer: routes for early recurrence after mastectomy and treatment for lobular and ductal forms of disease.
Saad HA; Baz A; Riad M; Eraky ME; El-Taher A; Farid MI; Sharaf K; Said HEM; Ibrahim LA
BMC Immunol; 2024 Jan; 25(1):9. PubMed ID: 38273260
[TBL] [Abstract] [Full Text] [Related]
15. Neoadjuvant chemotherapy-induced remodeling of human hormonal receptor-positive breast cancer revealed by single-cell RNA sequencing.
Jia F; Sun S; Li J; Wang W; Huang H; Hu X; Pan S; Chen W; Shen L; Yao Y; Zheng S; Chen H; Xia W; Yuan H; Zhou J; Yu X; Zhang T; Zhang B; Huang J; Ni C
Cancer Lett; 2024 Mar; 585():216656. PubMed ID: 38266804
[TBL] [Abstract] [Full Text] [Related]
16. Whole-tumor histogram models based on quantitative maps from synthetic MRI for predicting axillary lymph node status in invasive ductal breast cancer.
Zeng F; Yang Z; Tang X; Lin L; Lin H; Wu Y; Wang Z; Chen M; Chen L; Chen L; Wu PY; Wang C; Xue Y
Eur J Radiol; 2024 Mar; 172():111325. PubMed ID: 38262156
[TBL] [Abstract] [Full Text] [Related]
17. Using hybrid pre-trained models for breast cancer detection.
Zarif S; Abdulkader H; Elaraby I; Alharbi A; Elkilani WS; Pławiak P
PLoS One; 2024; 19(1):e0296912. PubMed ID: 38252633
[TBL] [Abstract] [Full Text] [Related]
18. Chemotherapy is of prognostic significance to metaplastic breast cancer.
Zhang M; Yuan J; Wang M; Zhang M; Chen H
Sci Rep; 2024 Jan; 14(1):1210. PubMed ID: 38216630
[TBL] [Abstract] [Full Text] [Related]
19. TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2
Shao X; Yang D; Shan L; Yan X; Xu D; Li L; Sun Y; Yu Q; Zhou H; Ding Y; Tang J
Arch Toxicol; 2024 Mar; 98(3):865-881. PubMed ID: 38212449
[TBL] [Abstract] [Full Text] [Related]
20. Impact of immunohistochemical expression of kinesin family member 18A (Kif18A) and β-catenin in infiltrating breast carcinoma of no special type.
Hemida AS; Shabaan MI; Taha MA; Abdou AG
World J Surg Oncol; 2024 Jan; 22(1):15. PubMed ID: 38195458
[TBL] [Abstract] [Full Text] [Related]
[Next]
